Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
251results about How to "Suitable viscosity" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Stable high protein concentration formulations of human Anti-tnf-alpha-antibodies
InactiveUS20100278822A1Suitable viscosityIncrease concentrationAntibacterial agentsSenses disorderHigh concentrationPolyol
The invention provides a liquid pharmaceutical formulation which does not include NaCl and comprises more than 20 mg of a polyol and at least about 100 mg / mL of a human anti-TNF-alpha antibody, or antigen-binding portion thereof. The invention provides a high concentration antibody formulation having long-term stability and advantageous characteristics for subcutaneous administration.
Owner:ABBVIE BIOTECHNOLOGY LTD
Lightweight proppant and method of making same
InactiveUS20060016598A1Manufactured usingSuitable viscosityFluid removalDrilling compositionPrillHigh intensity
A lightweight, high-strength proppant is disclosed, comprising the formation of finely dispersed ceramic precursors and sintering at low temperatures, causing the formation and retention of mesopores and micropores in pelletized ceramic. A method of manufacturing such a proppant is also disclosed, comprising the steps of manufacturing finely divided ceramic precursors and additives using grinding, milling, and preferably sol-gel processes, and dispersing the finely divided ceramic precursors and additives in a liquid, preferably water. The dispersion has a viscosity profile, which permits the shaping of spheres using conventional pelletizing techniques. Drying of the pellets and sintering at temperatures below 1,400.degrees. C. forms and retains mesopores and micropores in the ceramic. Preferred total pore volumes range from 0.05 to 0.7 cm.sup.3 / g. The pelletized and porous ceramic is useful as lightweight and high-strength proppants.
Owner:URBANEK THOMAS WILHELM
Fermented whey prepration and method for producing the same
InactiveUS20100136203A1Improve securityGreat tasteMilk preservationFood preservationWhey proteinVelvety texture
Disclosed is a fermented whey preparation produced by carrying out high-temperature sterilization of an aqueous whey protein solution having a solid content of 11 to 35% by weight and a pH value adjusted to 6.5 to 8.0, then subjecting the aqueous whey protein solution to lactic acid fermentation, and homogenizing the resultant fermentation liquor as such. The fermented whey preparation has a fermentation-derived unique and good flavor and, at the same time, has a refreshed and invigorating flavor and further has a velvety texture. The fermented whey preparation is also excellent in thermal stability and safety.
Owner:COPAL CO LTD +1
Two or more non-volatile solvent-containing compositions and methods for dermal delivery of drugs
InactiveUS20070196453A1Reduce deliveryEasy to disassembleOrganic active ingredientsMacromolecular non-active ingredientsEvaporationDermatology
The present invention is drawn to adhesive formulations, methods of drug delivery, and solidified layers for dermal delivery of a drug. The formulation can include a drug, a solvent vehicle, and a solidifying agent. The solvent vehicle can have a volatile solvent system including at least one volatile solvent, and a non-volatile solvent system including at least two non-volatile solvents. The formulation can have a viscosity suitable for application to a skin surface prior to evaporation of the volatile solvents system. When applied to the skin, the formulation can form a solidified layer after at least a portion of the volatile solvent system is evaporated.
Owner:NUVO RES
Compositions and methods for dermally treating musculoskeletal pain
InactiveUS20070189978A1Suitable viscosityFacilitate transdermal deliveryBiocidePeptide/protein ingredientsJoint painSkin treatments
The present invention is drawn to solidifying formulations for dermal delivery of a drug for treating musculoskeletal pain, inflammation, joint pain, etc. The formulation can include a drug selected from certain drug classes, a solvent vehicle, and a solidifying agent. The solvent vehicle can include a volatile solvent system having one or more volatile solvent, and a non-volatile solvent system having one or more non-volatile solvent, wherein the evaporation of at least some of the volatile solvent converts the formulation on the skin into a solidified layer and the non-volatile solvent system is capable of facilitating the topical delivery of the drug(s) at therapeutically effective rates over a sustained period of time.
Owner:ZARS INC
Adhesive solid gel-forming formulations for dermal drug delivery
The present invention is drawn to adhesive solid gel-forming formulations, methods of drug delivery, and solidified gel layers for dermal delivery of a drug. The formulation can include a drug, a solvent vehicle, and a gelling agent. The solvent vehicle can include a volatile solvent system having one or more volatile solvent, and a non-volatile solvent system having one or more non-volatile solvent, wherein at least one non-volatile solvent is flux-enabling non-volatile solvent(s) capable of facilitating the delivery of the drug at therapeutically effective rates over a sustained period of time. The formulation can have a viscosity suitable for application to a skin surface prior to evaporation of the volatile solvents system. When applied to the skin, the formulation can form a solidified gel layer after at least a portion of the volatile solvent system is evaporated. The solidified gel layer is can be removed by either peeling or washing using a designated solvent or solvents.
Owner:NUVO RES
Two or more non-volatile solvent-containing compositions and methods for dermal delivery of drugs
InactiveUS20120301517A1Reduce deliveryEasy to disassembleBiocideAmide active ingredientsSkin surfaceEvaporation
The present invention is drawn to adhesive formulations, methods of drug delivery, and solidified layers for dermal delivery of a drug. The formulation can include a drug, a solvent vehicle, and a solidifying agent. The solvent vehicle can have a volatile solvent system including at least one volatile solvent, and a non-volatile solvent system including at least two non-volatile solvents. The formulation can have a viscosity suitable for application to a skin surface prior to evaporation of the volatile solvents system. When applied to the skin, the formulation can form a solidified layer after at least a portion of the volatile solvent system is evaporated.
Owner:NUVO RES
Systems for custom coloration
ActiveUS20140082854A1Suitable viscosityOptical radiation measurementCosmetic preparationsFiberBiomedical engineering
Novel systems and methods for performing treatment (e.g., coloration) of keratinous fibers are disclosed. The methods and systems utilize one or more of a dispensing device which is configured to provide customized composition for treating keratinous fibers (e.g., a coloring composition), optionally formed from tablets; an optical reader, for obtaining sufficient characteristics of the keratinous fibers to make a realistic prediction of the outcome of a treatment (e.g., coloring treatment); a computational units for predicting an outcome of a treatment, optionally being interfaced with the dispensing device and for selecting a customized treatment; and tablet formulations which are useful in preparing customized composition for treating keratinous fibers. Further disclosed are rapidly disintegrating tablets for use in the preparation of compositions for treating keratinous fibers.
Owner:COLORIGHT
Thermosetting resin compositions containing maleimide and/or vinyl compounds
InactiveUS6852814B2Low water absorptionImprove adhesionOrganic chemistryLayered productsPliabilitySolvent
In accordance with the present invention, there are provided novel thermosetting resin compositions which do not require solvent to provide a system having suitable viscosity for convenient handling. Invention compositions have the benefit of undergoing rapid cure. The resulting thermosets are stable to elevated temperatures, are highly flexible, have low moisture uptake and are consequently useful in a variety of applictions, e.g., in adhesive applications since they display good adhesion to both the substrate and the device attached thereto.
Owner:HENKEL CORP
Compositions and methods for dermally treating infections
InactiveUS20070196325A1Sustained release of drugReduce deliveryAntimycoticsAntiviralsSkin treatmentsSkin surface
The present invention is drawn to solidifying adhesive formulations, methods of drug delivery, and solidified layers for dermal delivery of a drug which can treat various skin infections, such as fungal, bacterial, and / or viral skin infections. The formulation can include an anti-infective drug, a solvent vehicle, and a solidifying agent. The solvent vehicle can include a volatile solvent system including at least one volatile solvent, and a non-volatile solvent system including at least one non-volatile solvent. The non-volatile solvent system can facilitate the delivery of the drug at therapeutically effective rates for sustained period of time. The non-volatile solvent system can also act as a plasticizer for the solidifying agent. The formulation can have a viscosity suitable for application to a skin surface prior to evaporation of the volatile solvents system. When applied to the skin, the formulation can form a solidified layer after at least a portion of the volatile solvent system is evaporated.
Owner:NUVO RES
Compositions and methods for treating alopecia
InactiveUS20070189980A1Promote growthReduce deliveryBiocideCosmetic preparationsEvaporationDermatology
The present invention is drawn to adhesive solidifying formulations, methods of drug delivery, and solidified layers for topical delivery of drugs for treating alopecia. The formulation can include a drug for treating alopecia, a solvent vehicle, and a solidifying agent. The solvent vehicle can include a volatile solvent system having one or more volatile solvent, and a non-volatile solvent system having one or more non-volatile solvent which is capable of facilitating the delivery of the drug at therapeutically effective rates over a sustained period of time. The formulation can have a viscosity suitable for application to a skin surface as a layer prior to evaporation of the volatile solvents system. When applied to the skin, the formulation can form a solidified layer after at least a portion of the volatile solvent system is evaporated.
Owner:ZARS INC
Viscosity modification of petroleum distillates
InactiveUS20030083209A1Suitable viscosityHigh viscosityCosmetic preparationsMake-upMaceralPressurized spray
A method for the thickening of mineral oil products, wherein the thickened mineral oil product exhibits shear-thinning so as to be applicable to a surface by non-pressurized spray mechanisms. The thickening agent added to the petroleum distillate comprises a thixotropic thickener chosen from the group consisting of mixtures comprising a triblock copolymer and a hydrocarbon oil, and N-Lauroyl glutamic acid di-n-butylamide.
Owner:SC JOHNSON & SON INC
Systems for custom coloration
ActiveUS20150089751A1Suitable viscositySmall article dispensingCosmetic preparationsOptical readerBiomedical engineering
Novel systems and methods for performing treatment (e.g., coloration) of keratinous fibers are disclosed. The methods and systems utilize one or more of a dispensing device which is configured to provide customized composition for treating keratinous fibers (e.g., a coloring composition), optionally formed from tablets; an optical reader, for obtaining sufficient characteristics of the keratinous fibers to make a realistic prediction of the outcome of a treatment (e.g., coloring treatment); a computational units for predicting an outcome of a treatment, optionally being interfaced with the dispensing device and for selecting a customized treatment; and tablet formulations which are useful in preparing customized composition for treating keratinous fibers. Further disclosed are rapidly disintegrating tablets for use in the preparation of compositions for treating keratinous fibers.
Owner:COLORIGHT
Alpha-galactosidase A and 1-deoxygalactonojirimycin co-formulation for the treatment of fabry disease
ActiveUS10155027B2Reduce deliveryAdequate dosePeptide/protein ingredientsPharmaceutical delivery mechanismActive siteIn vivo
The present application provides compositions comprising α-galactosidase A in combination with an active site-specific chaperone for the α-galactosidase A, and methods for treating Fabry disease in a subject in need thereof, that includes a method of administering to the subject such compositions. The present application also provides methods for increasing the in vitro and in vivo stability of an α-galactosidase A enzyme formulation. The present application also provides methods for treating Fabry disease using intravenous administration of 1-deoxygalactonojirimycin.
Owner:AMICUS THERAPEUTICS INC
Thermosetting resin compositions containing maleimide and/or vinyl compounds
InactiveUS6960636B2Fast curingReduce moisture absorption performanceOrganic chemistryOther chemical processesSolventMoisture
In accordance with the present invention, there are provided novel thermosetting resin compositions which do not require solvent to provide a system having suitable viscosity for convenient handling. Invention compositions have the benefit of undergoing rapid cure. The resulting thermosets are stable to elevated temperatures, are highly flexible, have low moisture uptake and are consequently useful in a variety of applications, e.g., in adhesive applications since they display good adhesion to both the substrate and the device attached thereto.
Owner:HENKEL CORP
Composition for cleaning scalp and head hair
InactiveUS20130216491A1Excellent conditioning performanceSuitable viscosityCosmetic preparationsHair removalChemistryDandruff
Owner:OTSUKA PHARM CO LTD
Urethane polymer compositions
ActiveUS20030232956A1Increasing ultimate cohesive strengthImprove responseAdhesive processesPolyureas/polyurethane adhesivesPolymer sciencePolyol
Owner:ROHM & HAAS CO
Systems for custom coloration
Owner:COLORIGHT
Curable resin composition
A resin composition having a viscosity suitable for encapsulating optical devices such as light-emitting devices is provided. Specifically, the cured product of the resin composition has a refractive index greater than or equal to that of epoxy resins, exhibits excellent heat resistance and light resistance, and has thermal stress relaxation properties. The curable resin composition contains a fluorene group-containing acrylate or methacrylate represented by the following formula and a specific monofunctional acrylate or methacrylate:wherein X is —(CH2CH2O)n— or —(CH2CH2O)—CH2CH(OH)CH2O— with n being 1 to 5 and R is an acrylic or methacrylic group.
Owner:SONY CORP +1
Water-resistant optical cable and manufacturing method
InactiveUS7995886B2Suitable viscositySuitable wettabilityConfectioneryOptical articlesShear rateEngineering
A method for manufacturing an optical cable for communication includes at least one micromodule, said micromodule being blocked with respect to the propagation of water. The method includes the steps of providing at least one optical fiber; embedding the at least one optical fiber in a pseudoplastic filling compound having a viscosity of 3 Pa·s to 30 Pa·s, preferably 7 Pa·s to 25 Pa·s at a shear rate of 10 s−1 and at a temperature of 100° C., and a cross-over lower than 30 Hz, preferably 5 Hz to 25 Hz, at a temperature of 100° C.; and extruding a retaining element made of a thermoplastic polymeric composition around the at least one optical fiber so embedded in the filling compound to obtain a micromodule.
Owner:PRYSMIAN CAVI E SISTEMI ENERGIA
Deposition of phosphor on die top using dry film photoresist
ActiveUS8399268B1Suitable viscosityControl thicknessSolid-state devicesSemiconductor/solid-state device manufacturingPhotoresistEngineering
A method for depositing a layer of phosphor-containing material on a plurality of LED dies includes disposing a template with a plurality of openings on an adhesive tape and disposing each of a plurality of LED dies in one of the plurality of openings of the template. The method also includes forming a patterned dry film photoresist layer over the template and the plurality of LED dies. The photoresist layer has a plurality of openings configured to expose a top surface of each of the LED dies. Next, a phosphor-containing material is disposed on the exposed top surface of each the LED dies. The method further includes removing the photoresist layer and the template.
Owner:LEDENGIN
Controlled release topical testosterone formulations and methods
InactiveUS20150297733A1Constant effective testosterone blood levelEasy to useOrganic active ingredientsInorganic non-active ingredientsBlood levelControlled release
The present invention relates to testosterone topical formulations, especially high testosterone concentration formulations, such as between about 6% to about 15% w / w or higher, for the controlled release of testosterone into the systemic circulation of males and females for providing constant effective testosterone blood levels, without inducing undesired testosterone spike in blood levels or testosterone transference, following topical administration. The present invention also relates to methods and pre-filled multi-dose airless applicator systems for pernasal administration of the nasal testosterone gels of the present invention
Owner:ACERUS BIOPHARMA INC
Method for forming a patterned layer on a substrate
ActiveUS20100203235A1Suitable viscosityLow costSolid-state devicesCoatingsSurface finishingMaterials science
Owner:BEIJING XIAOMI MOBILE SOFTWARE CO LTD
Adhesives having advanced flame-retardant property
InactiveUS20050192392A1Improve flame retardant performanceImprove heat transfer efficiencyEster polymer adhesivesPolymer sciencePolymer resin
The present invention provides an adhesive comprising an acrylic polymer resin and a flame-retardant filler, in which the content of unreacted residual monomers in the adhesive, which are parts of monomers for forming the acrylic polymer resin and remain unreacted after a preparation process of the adhesive, is 2% or less by weight. Also, the present invention provides an adhesive sheet formed by applying the adhesive to one or both sides of a substrate. In addition, the present invention provides a method of controlling the flame retardancy of the adhesive by adjusting the content of the unreacted residual monomers in the adhesive.
Owner:LG CHEM LTD
Laminate panel without counteracting paper
ActiveUS20140329064A1Adjustable viscositySuitable viscosityRecord information storageMagnetic recordingEngineering
Owner:XYLO TECH AG
Semiconductor device and method for manufacturing same
InactiveUS20130009300A1Avoid downsizingIncrease the areaSemiconductor/solid-state device detailsSolid-state devicesDevice materialDie bonding
A dug portion (50) in which a die-bonding material is filled is provided to a lower surface of a stamping nozzle (42) used in a step of applying the die-bonding material onto a chip mounting portion of a wiring board. Planar dimensions of the dug portion (50) are smaller than external dimensions of a chip to be mounted on the chip mounting portion. In addition, a depth of the dug portion (50) is smaller than a thickness of the chip. When the thickness of the chip is 100 μm or smaller, a problem of crawling up of the die-bonding material to an upper surface of the chip is avoided by applying the die-bonding material onto the chip mounting portion using the stamping nozzle (42).
Owner:RENESAS ELECTRONICS CORP
Nanopastes as ink-jet compositions for printing plates
InactiveUS7081322B2Good ink absorptionSuitable for usePhotosensitive materialsDuplicating/marking methodsPhotochemistryImage area
The present invention provides a method of forming an image on a printing plate, in which a nanopaste is imagewise ink-jet applied onto a surface of a substrate. The layer is then treated to form an image area. The method is useful in the formation of printing plates and radiation opaque masks.
Owner:KODAK POLYCHROME GRAPHICS
Psa containing olefin block copolymers and styrene block copolymers
ActiveUS20140256867A1Suitable viscosityGood elastic behavior in bondingFilm/foil adhesivesNatural resin adhesivesPolystyreneHot melt
The invention relates to storage-stable hot-melt adhesive containing 15 to 70 wt % of a mixture of at least one copolymer based on ethylene and / or propylene and at least one C4 to C20 α-olefin which is obtainable as a block copolymer by metallocene-catalysed polymerisation, and at least one styrene block copolymer, 10 to 70 wt % of at least one tackifying resin, 0 to 40 wt % of further additives, wherein the total of the percentages should amount to 100% and the tackifying resin is entirely or in part a soft resin.13
Owner:HENKEL KGAA
Systems for custom coloration
Owner:COLORIGHT
High Concentration Alpha-Glucosidase Compositions for the Treatment of Pompe Disease
ActiveUS20140193390A1High protein concentrationIncrease protein aggregationOrganic active ingredientsNervous disorderDiseaseHigh concentration
The present application provides for compositions comprising high concentrations of acid α-glucosidase in combination with an active site-specific chaperone for the acid α-glucosidase, and methods for treating Pompe disease in a subject in need thereof, that includes a method of administering to the subject such compositions. The present application also provides methods for increasing the in vitro and in vivo stability of an acid α-glucosidase enzyme formulation.
Owner:AMICUS THERAPEUTICS INC
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com